Case, D C <br/><br/>
Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol.  [electronic resource] 

 -  The American journal of medicine  Dec 1977 
 - 897-903 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0002-9343 
<br/><br/><label>Standard No.: </label>10.1016/0002-9343(77)90543-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Carmustine--therapeutic use<br/>Cyclophosphamide--therapeutic use<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Immunoglobulin A<br/>Immunoglobulin G<br/>Immunoglobulin M<br/>Male<br/>Melphalan--therapeutic use<br/>Middle Aged<br/>Multiple Myeloma--drug therapy<br/>Prednisone--therapeutic use<br/>Remission, Spontaneous<br/>Time Factors<br/>Vincristine--therapeutic use